Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
January 5, 2000
Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells
H M Zarour, J M Kirkwood, L S Kierstead, et al.
Science (New York, N.Y.)
|
April 29, 1994
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
A L Cox, J Skipper, Y Chen, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 2, 1998
Complete spontaneous regression of pulmonary metastatic melanoma
T S Wang, L Lowe, J W Smith, et al.
International Journal of Cancer
|
September 25, 1999
Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines
L H Brinckerhoff, V V Kalashnikov, L W Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2001
Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations
G Yamshchikov, L Thompson, W G Ross, et al.
International Journal of Cancer
|
July 27, 1999
Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100
J C Skipper, P H Gulden, R C Hendrickson, et al.
The Journal of Experimental Medicine
|
January 31, 1998
The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol
C A Mosse, L Meadows, C J Luckey, et al.
British Journal of Cancer
|
December 18, 2001
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells
L S Kierstead, E Ranieri, W Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Patient preferences for adjuvant interferon alfa-2b treatment
K L Kilbridge, J C Weeks, A J Sober, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1996
Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100
J C Skipper, D J Kittlesen, R C Hendrickson, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Proceedings of the National Academy of Sciences of the United States of America
|
January 5, 2000
Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells
H M Zarour, J M Kirkwood, L S Kierstead, et al.
Science (New York, N.Y.)
|
April 29, 1994
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
A L Cox, J Skipper, Y Chen, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
September 2, 1998
Complete spontaneous regression of pulmonary metastatic melanoma
T S Wang, L Lowe, J W Smith, et al.
International Journal of Cancer
|
September 25, 1999
Terminal modifications inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines
L H Brinckerhoff, V V Kalashnikov, L W Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2001
Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations
G Yamshchikov, L Thompson, W G Ross, et al.
International Journal of Cancer
|
July 27, 1999
Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100
J C Skipper, P H Gulden, R C Hendrickson, et al.
The Journal of Experimental Medicine
|
January 31, 1998
The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol
C A Mosse, L Meadows, C J Luckey, et al.
British Journal of Cancer
|
December 18, 2001
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells
L S Kierstead, E Ranieri, W Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Patient preferences for adjuvant interferon alfa-2b treatment
K L Kilbridge, J C Weeks, A J Sober, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1996
Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100
J C Skipper, D J Kittlesen, R C Hendrickson, et al.
Page
of 6